PharmGKB summary: phenytoin pathway.

Article Details

Citation

Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB

PharmGKB summary: phenytoin pathway.

Pharmacogenet Genomics. 2012 Jun;22(6):466-70. doi: 10.1097/FPC.0b013e32834aeedb.

PubMed ID
22569204 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs
Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
PhenytoinCatechol O-methyltransferaseProteinHumans
No
Substrate
Details
PhenytoinCytochrome P450 2A6ProteinHumans
No
Substrate
Details
PhenytoinCytochrome P450 2B6ProteinHumans
No
Substrate
Inducer
Details
PhenytoinCytochrome P450 2C18ProteinHumans
No
Substrate
Details
PhenytoinCytochrome P450 2D6ProteinHumans
No
Substrate
Details
PhenytoinCytochrome P450 2E1ProteinHumans
No
Substrate
Details
PhenytoinCytochrome P450 3A5ProteinHumans
No
Substrate
Inducer
Details
PhenytoinCytochrome P450 3A7ProteinHumans
No
Substrate
Inducer
Details
PhenytoinEpoxide hydrolase 1ProteinHumans
No
Substrate
Details
PhenytoinNAD(P)H dehydrogenase [quinone] 1ProteinHumans
No
Substrate
Details
PhenytoinUDP-glucuronosyltransferase 1-1ProteinHumans
No
Substrate
Inducer
Details
PhenytoinUDP-glucuronosyltransferase 1-4ProteinHumans
No
Substrate
Details
PhenytoinUDP-glucuronosyltransferase 1-6ProteinHumans
No
Substrate
Inhibitor
Details
PhenytoinUDP-glucuronosyltransferase 1-9ProteinHumans
No
Substrate
Inhibitor
Details
Drug Transporters
DrugTransporterKindOrganismPharmacological ActionActions
PhenytoinP-glycoprotein 1ProteinHumans
Unknown
Substrate
Details
Drug Reactions
Reaction
Details
Drug Interactions
DrugsInteraction
Fosphenytoin
Fluconazole
The serum concentration of Fosphenytoin can be increased when it is combined with Fluconazole.
Fosphenytoin
Fosamprenavir
The serum concentration of Fosphenytoin can be decreased when it is combined with Fosamprenavir.
Phenytoin
Fluconazole
The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.
Phenytoin
Fosamprenavir
The serum concentration of Phenytoin can be decreased when it is combined with Fosamprenavir.